Perrigo Receives Final Approval for Generic Ofirmev

Perrigo announced that the Food and Drug Administration (FDA) has granted final approval for Acetaminophen Injection, the generic version of Mallinckrodt's Ofirmev.

Ofirmev is an intravenous analgesic/antipyretic indicated to manage mild to moderate pain, moderate to severe pain with adjunctive opioid analgesics, and to reduce fever. The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. 

Related Articles

Perrigo's Acetaminophen Injection will be available as 1000mg/100mL vials. 

For more information call (866) 634-9120 or visit Perrigo.com.

Loading links....